$2.27
00.00%
At Close: -
$2.27
00.00%
After Hours: 4:01 PM EDT
15 minutes delayed
Comments
Loading...
Augmedix
AUGXNASDAQ
Augmedix (NASDAQ:AUGX) Stock, Analyst Ratings, Price Targets, Forecasts
Augmedix Inc has a consensus price target of $5.5 based on the ratings of 6 analysts. The high is $6 issued by Benchmark on May 16, 2023. The low is $5 issued by Evercore ISI Group on April 9, 2024. The 3 most-recent analyst ratings were released by Lake Street, Evercore ISI Group, and B. Riley Securities on May 14, 2024, April 9, 2024, and April 3, 2024, respectively. With an average price target of $4.67 between Lake Street, Evercore ISI Group, and B. Riley Securities, there's an implied 105.58% upside for Augmedix Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
B. Riley Securities
Benchmark
1calculated from analyst ratings
Analyst Ratings for Augmedix
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | — | Lake Street | Brooks O'Neil | — | Downgrade | Buy → Hold | Get Alert |
| 05/14/2024 | Buy Now | 54.19% | Lake Street | Brooks O'Neil | $8 → $3.5 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | — | Maxim Group | Allen Klee | — | Downgrade | Buy → Hold | Get Alert |
| 04/09/2024 | Buy Now | 120.26% | Evercore ISI Group | Elizabeth Anderson | $4.5 → $5 | Upgrade | In-Line → Outperform | Get Alert |
| 04/03/2024 | Buy Now | 142.29% | B. Riley Securities | Neil Chatterji | → $5.5 | Reinstates | → Buy | Get Alert |
| 03/19/2024 | Buy Now | 98.24% | Evercore ISI Group | Elizabeth Anderson | $6.5 → $4.5 | Maintains | In-Line | Get Alert |
| 03/19/2024 | Buy Now | 120.26% | Maxim Group | Allen Klee | $6.5 → $5 | Maintains | Buy | Get Alert |
| 12/15/2023 | Buy Now | 164.32% | Evercore ISI Group | Elizabeth Anderson | → $6 | Initiates | → In-Line | Get Alert |
| 05/16/2023 | Buy Now | 164.32% | Benchmark | Bill Sutherland | → $6 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2023 | Buy Now | 142.29% | B. Riley Securities | Neil Chatterji | $5 → $5.5 | Maintains | Buy | Get Alert |
| 04/21/2023 | Buy Now | 252.42% | Maxim Group | Allen Klee | $5 → $8 | Maintains | Buy | Get Alert |
| 04/21/2023 | Buy Now | 164.32% | Benchmark | Bill Sutherland | $5 → $6 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | 120.26% | B. Riley Securities | Neil Chatterji | $4 → $5 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | Buy Now | 120.26% | Benchmark | Bill Sutherland | → $5 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | Buy Now | 120.26% | Maxim Group | Allen Klee | $4 → $5 | Maintains | Buy | Get Alert |
| 03/07/2022 | Buy Now | 164.32% | Lake Street | Brooks O'Neil | → $6 | Initiates | → Buy | Get Alert |
| 01/21/2022 | Buy Now | 164.32% | Maxim Group | Allen Klee | → $6 | Initiates | → Buy | Get Alert |
| 11/01/2021 | Buy Now | 164.32% | Benchmark | Bill Sutherland | — | Initiates | → Buy | Get Alert |
| 11/01/2021 | Buy Now | — | William Blair | Ryan Daniels | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Augmedix (AUGX) stock?
The latest price target for Augmedix (NASDAQ:AUGX) was reported by Lake Street on July 22, 2024. The analyst firm set a price target for $0.00 expecting AUGX to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Augmedix (AUGX)?
The latest analyst rating for Augmedix (NASDAQ:AUGX) was provided by Lake Street, and Augmedix downgraded their hold rating.
When was the last upgrade for Augmedix (AUGX)?
The last upgrade for Augmedix Inc happened on April 9, 2024 when Evercore ISI Group raised their price target to $5. Evercore ISI Group previously had an in-line for Augmedix Inc.
When was the last downgrade for Augmedix (AUGX)?
The last downgrade for Augmedix Inc happened on July 22, 2024 when Lake Street changed their price target from N/A to N/A for Augmedix Inc.
When is the next analyst rating going to be posted or updated for Augmedix (AUGX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Augmedix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Augmedix was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Augmedix (AUGX) correct?
While ratings are subjective and will change, the latest Augmedix (AUGX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Augmedix (AUGX) is trading at is $2.27, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.